Hyperinsulinaemia and hyperglycaemia: possible risk factors of colorectal cancer among diabetic patients.
about
Chemoprevention of colorectal cancer by targeting obesity-related metabolic abnormalitiesMetabolic abnormalities and risk for colorectal cancer in the physicians' health studyPrevention of Colorectal Cancer by Targeting Obesity-Related Disorders and Inflammation.Associations of diabetes mellitus with site-specific cancer mortality in the Asia-Pacific regionDiabetes promotes DMH-induced colorectal cancer by increasing the activity of glycolytic enzymes in rats.Nutraceutical approach for preventing obesity-related colorectal and liver carcinogenesis.Increased risk of colorectal cancer in type 2 diabetes is independent of diet quality.Relationship between Metabolic Syndrome and MTHFR Polymorphism in Colorectal Cancer.Physical activity as a determinant of fecal bile acid levels.Insulin, glucose, insulin resistance, and incident colorectal cancer in male smokers.C57BL/KsJ-db/db-Apc mice exhibit an increased incidence of intestinal neoplasms.Survival Benefit of Exercise Differs by Tumor IRS1 Expression Status in Colorectal Cancer.Aldose reductase inhibition suppresses azoxymethane-induced colonic premalignant lesions in C57BL/KsJ-db/db mice.Future directions for research on Silybum marianum for cancer patients.Metformin prevents DMH-induced colorectal cancer in diabetic rats by reversing the warburg effect.Melatonin induces apoptosis of colorectal cancer cells through HDAC4 nuclear import mediated by CaMKII inactivation.Inactivation of AMPK alters gene expression and promotes growth of prostate cancer cells.Diabetic biomarkers and the risk of proximal or distal gastric cancer.Preventive Effects of Pentoxifylline on the Development of Colonic Premalignant Lesions in Obese and Diabetic MiceEnhanced tumorigenesis of forestomach tumors induced by N-Methyl-N'-nitro-N-nitrosoguanidine in rats with hypoinsulinemic diabetes.Pitavastatin inhibits azoxymethane-induced colonic preneoplastic lesions in C57BL/KsJ-db/db obese mice.Measurement of biological age may help to assess the risk of colorectal adenoma in screening colonoscopy.Clinical study on the correlation between metabolic syndrome and colorectal carcinoma.Diabetes mellitus and risk of colorectal cancer in the Singapore Chinese Health Study.Ay allele promotes azoxymethane-induced colorectal carcinogenesis by macrophage migration in hyperlipidemic/diabetic KK mice.Relation of the IGF/IGF1R system to autophagy in colitis and colorectal cancer.Aldose reductase inhibitor, fidarestat prevents high-fat diet-induced intestinal polyps in ApcMin/+ mice.Metabolic syndrome: maladaptation to a modern world.
P2860
Q26995915-1C864F50-5992-47BB-AF53-F6CA0813EB51Q28212410-95621D3E-3070-4719-AAB5-9E65A09E0F6EQ33754774-23FD7EBB-D5E2-444C-A827-C0887D1AA8EDQ34222524-1A7BDCA7-E8DB-49BF-A63F-2429C5374C52Q34362225-42E166EF-06B6-47DB-B91D-CD4E030E4CA8Q34635693-C9918006-86BD-4B46-BBD6-C36FA0F53CA1Q34656265-E4DCC09A-1E79-4090-800B-E3858BACD0CDQ34971242-5DAD5FA2-985B-4668-A1D8-8279D859B2CDQ34977111-F528C38A-5DE0-4774-AE40-AA0D9FE06C9AQ35578858-39022427-C905-45C8-A10D-7C630FABB9F0Q35600230-F02CA4A3-401A-41F6-B567-668607820CFFQ36563705-B1E2EA51-856C-48A7-A3C5-B3DCF6CF16E9Q36585331-1AA99BC9-4C15-46DF-93EB-36FE80820326Q36840447-ED1E5627-E4FA-4566-9F9B-699E87E34561Q38834937-C87EFED2-413B-4998-B719-548B5220B7EAQ38902157-0DCD89B4-6C7B-4B7B-8004-F1DE482607DEQ39863992-E3774203-410D-4831-BED4-4FC2941AC393Q40511318-FAC6D1B2-7090-4702-A179-037012649F34Q42317350-FF8201DC-BC7D-4482-A0E9-0AFFFD78922CQ43055619-A85B19D0-F1FF-4A89-BB93-552E360E8875Q43096531-E37D2A64-35E7-4B55-8E4B-C14C766AEC9EQ43281963-7A15EBC1-D386-40BC-9267-D999AFB26480Q43764414-04EF0C5E-1A04-4FCA-B67D-0FDF7E41DE6EQ44489652-F77388FE-2CF2-4C51-9DDC-52D9129E839CQ45153009-0CF64DCF-B295-403B-8C32-C7051672F121Q48553803-AB82986B-FB81-43DF-B107-568AAE7BE8C2Q53183762-05410D02-CDA3-4733-9E13-4D7023E70C3CQ53880980-BC000F8A-ABAC-414C-882C-9B33BDBCE224
P2860
Hyperinsulinaemia and hyperglycaemia: possible risk factors of colorectal cancer among diabetic patients.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Hyperinsulinaemia and hypergly ...... ancer among diabetic patients.
@ast
Hyperinsulinaemia and hypergly ...... ancer among diabetic patients.
@en
type
label
Hyperinsulinaemia and hypergly ...... ancer among diabetic patients.
@ast
Hyperinsulinaemia and hypergly ...... ancer among diabetic patients.
@en
prefLabel
Hyperinsulinaemia and hypergly ...... ancer among diabetic patients.
@ast
Hyperinsulinaemia and hypergly ...... ancer among diabetic patients.
@en
P2860
P1433
P1476
Hyperinsulinaemia and hypergly ...... ancer among diabetic patients.
@en
P2093
P2860
P2888
P304
P356
10.1007/S00125-003-1109-5
P577
2003-05-23T00:00:00Z